Serum Institute of India (SII) | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
June 16, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JUNE 16, 2025

Serum Institute of India (SII)

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas
Coronavirus chronicle

Serum CEO ‘flees India’ over threats

I’m staying here (London) an extended time because I don't want to go back to that situation, he says

Beximco profits Tk77 per vaccine brought from India
Economy

Beximco profits Tk77 per vaccine brought from India

Photo: NDTV
Coronavirus chronicle

Covishield production in full swing, says SII CEO Adar Poonawalla

Serum CEO Adar Poonawalla/Courtesy
South Asia

Serum Institute's Adar Poonawalla to get Y category security across India

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio
Coronavirus chronicle

Covishield price for Indian states reduced from Rs400 to Rs300 per dose

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

Indian govt tells Serum Institute, Bharat biotech to lower their Covid vaccine prices

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas
Coronavirus chronicle

‘Covishield most affordable Covid-19 jab’: SII calls out ‘inaccurate comparison’

Serum CEO Adar Poonawalla/Courtesy
Coronavirus chronicle

Vaccine exports may resume in June-July, Serum CEO hopes

The White House is pictured shortly after sunrise in Washington/Reuters
Coronavirus chronicle

WH uncertain over lifting curbs on vaccine raw materials export to India

Employees operate a filling machine inside a lab at the Serum Institute of India, in Pune, India, November 30, 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/Files
Coronavirus chronicle

India to fund capacity boost at Serum Institute as vaccines run short

FILE PHOTO: A woman speaks inside a waiting zone area at a health clinic where COVID-19 vaccination is being given to healthcare workers in Kolkata, India, February 1, 2021. REUTERS/Rupak De Chowdhuri/File Photo
Coronavirus chronicle

India reports Covid-19 vaccine shortage as second wave surges record highs

Serum CEO Adar Poonawalla/Courtesy
Coronavirus chronicle

Serum Institute appeals to Biden to lift embargo on raw material exports

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

COVAX says India's Serum Institute bound to supply virus vaccines

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net